» Articles » PMID: 33135632

EIF4E S209 Phosphorylation Licenses Myc- and Stress-driven Oncogenesis

Overview
Journal Elife
Specialty Biology
Date 2020 Nov 2
PMID 33135632
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

To better understand a role of eIF4E S209 in oncogenic translation, we generated heterozygous knockin (4EKI) HCT 116 human colorectal cancer (CRC) cells. 4EKI had little impact on total eIF4E levels, cap binding or global translation, but markedly reduced HCT 116 cell growth in spheroids and mice, and CRC organoid growth. 4EKI strongly inhibited Myc and ATF4 translation, the integrated stress response (ISR)-dependent glutamine metabolic signature, AKT activation and proliferation in vivo. 4EKI inhibited polyposis in mice by suppressing Myc protein and AKT activation. Furthermore, p-eIF4E was highly elevated in CRC precursor lesions in mouse and human. p-eIF4E cooperated with mutant to promote Myc and ISR-dependent glutamine addiction in various CRC cell lines, characterized by increased cell death, transcriptomic heterogeneity and immune suppression upon deprivation. These findings demonstrate a critical role of eIF4E S209-dependent translation in Myc and stress-driven oncogenesis and as a potential therapeutic vulnerability.

Citing Articles

RNA-binding proteins as therapeutic targets in cancer.

Jungfleisch J, Gebauer F RNA Biol. 2025; 22(1):1-8.

PMID: 40016176 PMC: 11869776. DOI: 10.1080/15476286.2025.2470511.


PRSS23-eIF4E-c-Myc axis promotes gastric tumorigenesis and progression.

Zhou X, Guo Z, Pan Y, Yang S, Yan R Oncogene. 2025; .

PMID: 39920289 DOI: 10.1038/s41388-025-03294-3.


PPM1G dephosphorylates eIF4E in control of mRNA translation and cell proliferation.

Wang P, Li Z, Kim S, Xu H, Huang H, Yang C Life Sci Alliance. 2024; 7(10).

PMID: 39111820 PMC: 11306785. DOI: 10.26508/lsa.202402755.


GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors.

Yamamoto V, Ha D, Liu Z, Huang M, Samanta S, Neamati N Neoplasia. 2024; 55:101020.

PMID: 38991376 PMC: 11294750. DOI: 10.1016/j.neo.2024.101020.


Molecular interaction and MD-simulations: investigation of Sizofiran as a promising anti-cancer agent targeting eIF4E in colorectal cancer.

Samykannu G, Mariyappan N, Natarajan J In Silico Pharmacol. 2024; 12(1):33.

PMID: 38655099 PMC: 11033251. DOI: 10.1007/s40203-024-00206-3.


References
1.
Zhang L, Yu J . Role of apoptosis in colon cancer biology, therapy, and prevention. Curr Colorectal Cancer Rep. 2013; 9(4). PMC: 3836193. DOI: 10.1007/s11888-013-0188-z. View

2.
Luo J, Solimini N, Elledge S . Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. 2009; 136(5):823-37. PMC: 2894612. DOI: 10.1016/j.cell.2009.02.024. View

3.
Appenzeller-Herzog C, Hall M . Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol. 2012; 22(5):274-82. DOI: 10.1016/j.tcb.2012.02.006. View

4.
Topisirovic I, Ruiz-Gutierrez M, Borden K . Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities. Cancer Res. 2004; 64(23):8639-42. DOI: 10.1158/0008-5472.CAN-04-2677. View

5.
Yu J, Yue W, Wu B, Zhang L . PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation. Clin Cancer Res. 2006; 12(9):2928-36. DOI: 10.1158/1078-0432.CCR-05-2429. View